30+ competitors analysed across four categories: direct B2C MRI clinics (Prenuvo, Ezra, Neko, Q Bio, Human Longevity, SimonMed, Echelon), Singapore hospital screening (Raffles, Mt Elizabeth, AsiaMedic, Lifescan), Malaysian hospitals (Gleneagles JB, Sunway, Pantai), and adjacent longevity retreats (Clinique La Prairie, Lanserhof, Chenot, RAKxa, COMO Shambhala). Focus is on real product, real prices, real online sentiment, and the live clinical-evidence debate — not on logos and homepages.
The B2C category that defines public perception of "longevity scanning."
| Brand | Markets | Scan | Tech | Entry | Top tier | Reputation cue |
|---|---|---|---|---|---|---|
| PrenuvoVancouver / 25 clinics | USA · UK · CA · AU | ~60 min | 3T MRI · AI-assist | US$999 | US$5,000 Exec annual |
Lawsuit · Jan 2026 |
| Ezraacq. by Function · May 2025 | USA · ~50 partner sites | 22 min Flash AI |
1.5T/3T partner | US$499 Slashed from $1,500+ |
US$1,950 | Mass-market pivot |
| Function Health$2.5B valuation | USA · digital-first | n/a | 160+ biomarkers + Ezra MRI | US$365/yr + $499 MRI |
US$864 | Rising · celeb-backed |
| Neko HealthDaniel Ek · Spotify co-founder | Sweden · UK · Germany | ~20 min | 3D laser + bloods (NOT MRI) | £299 | £299 Flat |
Booking chaos |
| Q BioRedwood City | California | ~75 min | Mark I upright + 350 measures | ~US$3,500 | ~US$3,500 | Niche · digital twin |
| Human LongevityFounder: Craig Venter | San Diego | Full day | WB-MRI + WGS + cardiac | US$8,000 | US$19,000/yr | Premium · scientific |
| SimonMed (simonONE)170+ US centres | USA | 20–30 min | Hospital MRI + AI | US$650 | US$1,550 | Safety incidents 2025 |
| Echelon HealthMayfair · concierge | London | Full day | 3T MRI + CT + DEXA + bloods | £2,000 | £14,000 Platinum |
Closest analogue |
The actual price ceiling AEVUM anchors against — premium hospital concierge, not Ezra/Prenuvo.
| Brand · Top Package | Price (SGD) | What's included | Format | vs AEVUM |
|---|---|---|---|---|
| Mount ElizabethScreen Excelsior · Parkway Shenton | S$12,388 (M) S$12,888 (F) |
All diagnostics + private lounge + care manager | Premium hospital concierge | AEVUM Platinum 35–40% cheaper |
| Raffles MedicalRaffles Platinum | S$11,408 (M) S$11,530 (F) |
Endoscopy + cardiac + radiology + labs | Half/full-day hospital | AEVUM Platinum ~35% cheaper |
| Lifescan Medical3 SG centres · advanced tier | S$7,588 | MRI + 50-cancer screen | Standalone screening | Nearest direct comp |
| AsiaMedic · Navigator 7Top tier | S$4,600 | One of most in-depth full-body | Standalone screening | Comprehensive overlap |
| Thomson MedicalPrestige tier | S$2,869–3,188 | Comprehensive labs + imaging | Hospital screening | Below Comprehensive |
| ATA MedicalCustomisable | From S$76 + add-ons | Basic to executive | High-volume affordable | Different segment |
| Healthscreening.sgCHAS-accredited | From S$76 + MRI from S$1,090 | Add-on full-body MRI | Affordable | Different segment |
Singapore's premium anchor is S$11,400–S$12,900 — but those packages include endoscopy and concierge, NOT a true 60-min full-body MRI. There is no Singapore equivalent of Prenuvo/Ezra at scale. AEVUM's Comprehensive (RM 8,699 ≈ S$2,640) sweet-spots between Lifescan and AsiaMedic; Legacy Platinum (RM 24,499 ≈ S$7,420) is 35–40% below the SG hospital ceiling.
— Synthesis · April 2026The category is wide open — no Malaysian provider currently offers a Prenuvo/Ezra-style branded longevity full-body MRI.
| Brand | MRI / package price (RM) | Notes | Threat level |
|---|---|---|---|
| Gleneagles Hospital JohorMedini · IHH-owned | Quoted on request | Direct neighbour to AEVUM. Already serves Singapore cross-border. The most credible adjacent player. | High · adjacent |
| Sunway Medical (KL)3T scanner · medical tourism | RM 1,500–3,000 / MRI | Tiered wellness packages. KL location buffer; not in JB. | Low · KL-based |
| Pantai Hospital (IHH)KL / Ampang | From RM 1,000 Premium Women RM 1,880 |
Broad network, hospital pricing. | Low |
| Subang Jaya Medical CentreSJMC | Year-end RM 794 promo Heart RM 3,000 |
Mass-market pricing. | Low |
| Regency Medical (JB)Cross-border focus | n/a | Targets cross-border Singaporeans. Direct geographic competitor but not premium. | Medium · JB direct |
| Omega Clinic (JB)Boutique | n/a | Doctor-led check-ups. Smaller boutique. | Low |
Not direct competitors, but the brands AEVUM should learn aesthetic and pricing language from for the Legacy tiers.
| Brand | Location | Entry | Top program | Relevance to AEVUM |
|---|---|---|---|---|
| Clinique La PrairieGlobal gold standard | Montreux, CH | CHF 14,900 Life Reset |
CHF 48,520 Legendary Premium |
Brand language to borrow for Legacy Platinum messaging. |
| Lanserhof"World's Best Medical Spa" | DE/AT · 3 sites | €5,390 7 nights |
€8,175+ Bespoke |
Long-stay model — useful framing for "longevity weekend." |
| Chenot Palace WeggisLake Lucerne | Switzerland | €1,200/day all-in | CHF 6,900 7 nights |
AEVUM Platinum (RM 24,499) ≈ 5-night Chenot stay. |
| SHA WellnessGenetics + biomarkers | Alicante, Spain | €7,500 7 nt Advanced Longevity |
€12,000 14 nights |
Genetic add-on as future AEVUM expansion. |
| RAKxaClosest Asia analogue | Bangkok, TH | ~€800/day · US$5,279/3 nt | US$7,350 5 nights |
Direct partner / referral candidate. Asia HNW already books here. |
| COMO ShambhalaSG HNW touchstone | Ubud, Bali | ~€500/day | 5–10 night programs | Indonesian HNW touchstone. Source of demand for AEVUM. |
| REVĪVŌ WellnessBali · 6 retreats | Nusa Dua, Bali | IDR 6.8M ~US$415/night |
Signature longevity | Bali wellness halo — co-marketing potential. |
Real review sentiment, distilled. Not website attractiveness — what users actually say after the scan.
Heavily covered in the radiology press. Will define category perception for the rest of the year.
Sean Clifford, 37, paid US$2,500 for an NYC scan in July 2023. The cerebral and cerebellar vasculature read came back "normal." In March 2024, he suffered a catastrophic ischemic stroke (right middle cerebral artery territory), resulting in left-side paralysis and permanent disability.
Plaintiffs allege "worrisome arterial stenosis in right middle cerebral artery" was visible on the original scan and missed. Prenuvo attempted to apply California's damages cap; the New York court rejected that motion in January 2026 and the case is proceeding.
Implications for AEVUM:
1. Marketing must NOT promise "early detection of all cancers" or "find disease before symptoms" without heavy disclaimers — these claims are now legally and reputationally risky.
2. Radiologist quality is the moat. AEVUM should publish credentials, double-read protocols, and turnaround SLAs explicitly.
3. Incidental findings management is a product, not an afterthought. A "next-step concierge" (specialist booking, second opinion, anxiety counselling) is differentiating.
4. Position as "longevity baseline + concierge" — not "cancer screening." This avoids the strongest critique.
Major medical bodies oppose asymptomatic WB-MRI screening. AEVUM must engage with this honestly, not skirt it.
American College of Radiology (ACR): explicitly does not recommend total-body screening MRI for average-risk asymptomatic adults — citing no evidence of life extension or cost-effectiveness, and concern about non-specific findings driving downstream testing.
Canadian Association of Radiologists (CAR), Sept 2025 policy: opposes whole-body MRI as a screening tool in asymptomatic individuals outside specific evidence-based clinical indications.
Michigan Medicine, Fred Hutch (2025): "Pricey whole-body MRIs don't add up."
Structural tailwinds: RTS Link, ASEAN wellness CAGR 12.4%, Singapore HNW health anxiety, Indonesian HNW orbit.
The Johor Bahru–Singapore Rapid Transit System launches end-2026. Woodlands North to Bukit Chagar in 5 minutes, fares S$5–7, AI e-gates with 7-second clearance. Capacity: 40,000 pax/day at launch, 140,000/day long-term.
Pre-RTS, JB is for price-sensitive Singaporeans willing to drive. Post-RTS, JB is a 5-minute Uber from Woodlands — same effective distance as Mt Elizabeth Novena from Orchard.
AEVUM's go-to-market should backsolve from RTS launch month.
Chi Longevity opened at Four Seasons Singapore, January 2025 — luxury-hospitality longevity model. Validates AEVUM's positioning.
Morrow (Singapore longevity hub) opened December 2025 — democratising version.
Healthway, Nuffield, The Longevity GP, Clifford Clinic all entering longevity space.
JB is uncontested — but the SG shoulder has 18 months to react.
Synthesised from the full research set. These shape every messaging decision in the brand.
The Singapore HNW competitive set isn't Ezra at US$499 — it's Raffles Platinum at S$11,408. AEVUM's 35–40% price advantage vs. SG hospital concierge is the durable wedge. Position against Mt Elizabeth, not against Prenuvo.
Every competitor that has gone viral (Neko, Prenuvo, Chi Longevity at Four Seasons) won on physical experience + brand. The MRI machine is undifferentiated commodity. AEVUM should look more like Aman than KPJ — steal language from CLP/Chenot, not from Pantai.
The Prenuvo lawsuit, ACR/CAR opposition, and Fred Hutch/Michigan critiques mean asymptomatic WB-MRI is in a credibility war. AEVUM should: hire publicly named credentialed radiologists, publish a double-read protocol, frame as "personalised longevity baseline" (not "cancer screening"), and build the Specialist Concierge product — what happens after a finding is the real luxury.
End-2026 is when AEVUM's TAM 5×s. AEVUM's go-to-market plan should backsolve from RTS launch month. Pre-launch hype + early-adopter referral list timed to RTS opening = founders' moment. Soft-launch with a paid pilot Q3 2026; full launch at RTS opening.
Indonesia wellness tourism: US$7.9B → US$20.6B 2026–2035 (CAGR 11.3%). Indonesian HNW already travel to Singapore for finance and Bali for wellness. AEVUM could be the medical screening anchor of an Indonesia–Singapore–JB triangle for jetset clients (private plane to Senai, RTS to Singapore for shopping/banking, return flight via JB). Marketing: Bahasa Indonesia microsite, Jakarta-based ambassador (KOL doctor or wellness figure), partnerships with Mandiri Private / BCA Prioritas / DBS Treasures for warm referrals.